Unknown PHASE4 INTERVENTIONAL 2-arm NCT01001962

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics (PREHYPD)

Double Blind Comparison Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics With Metformin

Sponsor: Aristotle University Of Thessaloniki

Conditions Hypertension Type II Diabetes

Updated 6 times since 2017 Last updated: Apr 6, 2015 Started: Jan 31, 2016 Primary completion: Jan 31, 2019 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension and Type II Diabetes, this trial is ongoing. The trial is conducted by Aristotle University Of Thessaloniki and has accumulated 6 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Feb 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece